Answers are grounded in this paper and cite their sources.
Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs. Clinical Trials Registration clinicaltrials.gov (NCT03590808).
No takes yet. Share an insight, caveat, or question.
Keam et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: